title: Long-lasting complete remission with tyrosine kinase inhibitor in bronchioloalveolar carcinoma with a so far unknown EGFR mutation.
authors: Vienna
authors: V
authors: Ludovini
authors: Stefania
authors: S
authors: Gori
authors: Lorenza
authors: L
authors: Pistola
authors: Maria Agnese
authors: MA
authors: Della Fazia
authors: Danilo
authors: D
authors: Piobbico
authors: Giuseppe
authors: G
authors: Servillo
authors: Antonella
authors: A
authors: Flacco
authors: Cristina
authors: C
authors: Scuderi
authors: Lucio
authors: L
authors: Crinò
mesh_terms: D002282:Adenocarcinoma, Bronchiolo-Alveolar / Q000188:drug therapy* / Q000235:genetics* / Q000556:secondary; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D002945:Cisplatin / Q000008:administration & dosage; D003841:Deoxycytidine / Q000008:administration & dosage / Q000031:analogs & derivatives; D066246:ErbB Receptors / Q000037:antagonists & inhibitors / Q000235:genetics*; D006801:Humans; D007124:Immunoenzyme Techniques; D017404:In Situ Hybridization, Fluorescence; D008175:Lung Neoplasms / Q000188:drug therapy* / Q000235:genetics* / Q000473:pathology; D008297:Male; D008875:Middle Aged; D009154:Mutation / Q000235:genetics*; D011505:Protein-Tyrosine Kinases / Q000037:antagonists & inhibitors* / Q000378:metabolism; D012074:Remission Induction; D015898:Tomography Scanners, X-Ray Computed; D000093542:Gemcitabine
chemical_list: D003841:Deoxycytidine; D066246:ErbB Receptors; D011505:Protein-Tyrosine Kinases; D002945:Cisplatin; D000093542:Gemcitabine